Stocks · Health care · Pharmaceutical Preparations

PepGen Inc.

PEPG Clue Score35
United States Fiscal year ends December CIK 0001835597 Results filed 6 Aug 2026

What the insiders did Net buying

By person

13 insiders · 44 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Ra Capital Management, L.p. entity
Director
$95.96M (4)
—
+$95.96M
18,554,273
$26.17M
—
James E Flynn
10% owner
$5.00M (2)
—
+$5.00M
476,813
$672.64K
—
Michelle L Mellion
Chief Medical Officer
—
$905.69K (12) scheduled
−$905.69K
0
$0.00
—
Oxford Science Enterprises plc entity
Former 10% Owner
$640.00K (1)
—
+$640.00K
4,955,388
$6.99M
+396.1%
James G McArthur
President and CEO
$68.33K (3)
$538.23K (7) scheduled
−$469.90K
296,326
$418.03K
—
Niels Svenstrup
SVP, Chem. Mfg & Controls
—
$134.10K (1)
−$134.10K
0
$0.00
—
Jaya Goyal
EVP, Res. & Preclin. Dev.
—
$110.57K (4) scheduled
−$110.57K
0
$0.00
—
Laurie Keating
Director
$49.99K (1)
—
+$49.99K
4,166
$5.88K
—
Noel Donnelly
Chief Financial Officer
—
$15.55K (3)
−$15.55K
111,603
$157.44K
+834.9%
Mary Beth DeLena
General Counsel
—
$2.41K (1)
−$2.41K
14,968
$21.12K
—
Kasra Kasraian
Chief Technical Officer
—
$1.74K (1)
−$1.74K
50,074
$70.64K
—
Paul Streck
EVP, Head of R&D
$10.39K (1)
$11.71K (2)
−$1.32K
76,226
$107.53K
—
Joseph Vittiglio
Chief Business & Legal Officer
—
—
—
65,717
$92.71K
—

No percentages here. This company's share count has moved by a factor of 2.1 over the window, from 32,720,943 to 69,259,517 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.